Business Description
Oxygenta Pharmaceutical Ltd
ISIN : INE102E01018
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -0.32 | |||||
Debt-to-Equity | -2.84 | |||||
Debt-to-EBITDA | -5.95 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.66 | |||||
Beneish M-Score | 2.04 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -32.7 | |||||
3-Year FCF Growth Rate | 6.4 | |||||
3-Year Book Growth Rate | 45.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.79 | |||||
9-Day RSI | 38.75 | |||||
14-Day RSI | 41.37 | |||||
6-1 Month Momentum % | 4 | |||||
12-1 Month Momentum % | -24.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.31 | |||||
Days Inventory | 113.22 | |||||
Days Sales Outstanding | 103.7 | |||||
Days Payable | 213.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -48.6 | |||||
Shareholder Yield % | 6.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -3.34 | |||||
Operating Margin % | -31.17 | |||||
Net Margin % | -8.78 | |||||
FCF Margin % | -43.28 | |||||
ROA % | -5.75 | |||||
ROIC % | -7.45 | |||||
ROC (Joel Greenblatt) % | -39.6 | |||||
ROCE % | -43.39 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.65 | |||||
EV-to-EBIT | -14.17 | |||||
EV-to-EBITDA | -18.1 | |||||
EV-to-Revenue | 4.39 | |||||
EV-to-FCF | -10.26 | |||||
Earnings Yield (Greenblatt) % | -7.05 | |||||
FCF Yield % | -14.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Oxygenta Pharmaceutical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 396.421 | ||
EPS (TTM) (₹) | -1.09 | ||
Beta | 2.96 | ||
Volatility % | 52.94 | ||
14-Day RSI | 41.37 | ||
14-Day ATR (₹) | 2.185225 | ||
20-Day SMA (₹) | 34.5715 | ||
12-1 Month Momentum % | -24.4 | ||
52-Week Range (₹) | 25.02 - 52.27 | ||
Shares Outstanding (Mil) | 35.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Oxygenta Pharmaceutical Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Oxygenta Pharmaceutical Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Oxygenta Pharmaceutical Ltd Frequently Asked Questions
What is Oxygenta Pharmaceutical Ltd(BOM:524636)'s stock price today?
When is next earnings date of Oxygenta Pharmaceutical Ltd(BOM:524636)?
Does Oxygenta Pharmaceutical Ltd(BOM:524636) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |